Rucaparib: A Promising PARP Inhibitor in Ovarian a..

创建了一篇新文章

9 在

Rucaparib: A Promising PARP Inhibitor in Ovarian and Prostate Cancer Treatment | #rucaparib Wholesaler

Rucaparib: A Promising PARP Inhibitor in Ovarian and Prostate Cancer Treatment

Rucaparib: A Promising PARP Inhibitor in Ovarian and Prostate Cancer Treatment

Rucaparib is approved for the treatment of women with advanced ovarian cancer who have received two or more lines of chemotherapy and whose tumors exhibit BRCA mutations.

喜欢

评论

分享